Bad fungus is spreading in hospitals at an 'alarming rate.' What to know.

The CDC is taking this fungal infection seriously.
By Mark Kaufman  on 
spores of the Candida auris fungus
A microscopic view of spores of the Candida auris fungus. Credit: BSIP / Education Images / Universal Images Group via Getty Images

It's not a fungus apocalypse. But it's a serious, growing problem.

The Centers for Disease Control and Prevention (CDC) announced this week that the fungus Candida auris (C. auris) "spread at an alarming rate in U.S. healthcare facilities" during 2020-2021. This fungus is particularly problematic because it's a strain that has emerged in recent years, can be resistant to some, or all, antifungal drugs, and has caused outbreaks in hospitals, Dr. Luis Ostrosky, an M.D., fungal infection expert, and professor of infectious diseases at UTHealth Houston, recently told Mashable.

The CDC is taking the spread, which can cause severe and fatal blood infections, seriously.

"The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control," CDC epidemiologist Dr. Meghan Lyman, lead author of the new research, said in a statement.

The research, entitled, "Worsening Spread of Candida auris in the United States, 2019 to 2021," is published in the medical journal Annals of Internal Medicine.

How worried should you be about Candida auris?

The fungus Candida auris, which is a yeast, infects people who are quite ill and have compromised immune systems.

"To experience a fungal infection, there has to be something wrong with your immune system," Dr. Ostrosky, who is also chief of epidemiology at the academic hospital Memorial Hermann, explained. This includes people who have had organ transplants or other major, life-saving surgeries, as well as those undergoing cancer treatments, he said.

Mashable Light Speed
Want more space and science stories in your inbox?
Sign up for Mashable's weekly Light Speed newsletter.
By signing up you agree to our Terms of Use and Privacy Policy.
Thanks for signing up!
"In general, C. auris is not a threat to healthy people."

People in hospitals who are unwell are particularly susceptible to Candia auris. "People who are very sick, have invasive medical devices, or have long or frequent stays in healthcare facilities are at increased risk for acquiring C. auris," the CDC said.

Fortunately, like with most fungal spores, healthy people are not the group being infected or at risk. "In general, C. auris is not a threat to healthy people," the agency noted. That's because our advanced, healthy immune systems constantly combat fungal spores, and keep such foreign fungi microbes at bay. (For example, we inhale fungal spores every time we go outside.) "Humans are really, really good at staving off fungal infections," Vincent Bruno, a scientist at the Institute for Genome Sciences at the University of Maryland School of Medicine who researches fungal diseases, told Mashable this year.

Want more science and tech news delivered straight to your inbox? Sign up for Mashable's Top Stories newsletter today.

But for those infected with Candia auris, the CDC is raising the alarm because it's often resistant to multiple antifungal drugs that doctors use to treat Candida infections. Candida auris is a newly emerged strain of the fungus Candida, which already causes some 25,000 infections annually. Some 30 to 60 percent of people infected with C. auris have died, the CDC said. "However, many of these people had other serious illnesses that also increased their risk of death," the agency noted.

How much is Candida auris spreading?

Since 2016, the CDC has been increasingly concerned about Candida auris. That's when the health agency received reports that the fungus was resistant to medicines in other parts of the world.

"It seemed hard to believe," the CDC wrote. "CDC fungal experts had never received a report describing a Candida infection resistant to all antifungal medications, let alone Candida that spreads easily between patients."

  • Reported cases, though overall low in numbers, have been rising significantly since 2015. Cases increased 318 percent in 2018, compared to the previous few years, resulting in a total of 323 clinical cases.

  • Crucially, Candida auris cases have only increased each year since 2016. "Nationwide, clinical cases rose from 476 in 2019 to 1,471 in 2021," the CDC just concluded.

  • Case counts again increased in 2022, the agency noted.

    Counts of reported Candida auris cases in the U.S. in 2022.
    Counts of reported Candida auris cases in the U.S. in 2022. Credit: CDC

A number of factors may contribute to these rising numbers, the agency notes. This includes poor infection control, more screening to detect the infection (a good thing), and increased fungal spread during a time of great strain on the healthcare system during peaks of the COVID pandemic hospitalizations.

To limit the spread, the CDC is sounding the alarm to aid healthcare facilities in identifying the infectious fungus, and how to contain the microbe in places like hospitals and nursing homes.

This story was originally published on March 21, and has been updated with more information about Candida auris.

Topics Health

Mashable Image
Mark Kaufman

Mark is an award-winning journalist and the science editor at Mashable. After communicating science as a ranger with the National Park Service, he began a reporting career after seeing the extraordinary value in educating the public about the happenings in earth sciences, space, biodiversity, health, and beyond. 

You can reach Mark at [email protected].


Recommended For You
Sam Bankman-Fried sentenced to 25 years in prison
Former FTX CEO Sam Bankman-Fried arrives for a bail hearing at Manhattan Federal Court on August 11, 2023 in New York City. Federal prosecutors are asking U.S. District Court Judge Lewis Kaplan to revoke Bankman-Fried's bail and to be jailed until his October criminal trial. Bankman-Fried who has pleaded not guilty to multiple conspiracy and fraud charges was accused of witness tampering after the New York Times published a story featuring personal documents of Caroline Ellison, former Alameda Research CEO. Judge Kaplan will also hear arguments on the gag order placed on Bankman-Fried that was placed as part of his bail agreement for the alleged witness tampering.

Meta and Google fuel abortion misinformation across Africa, Asia, and Latin America, report finds
In this photo illustration, a person looks at an Abortion Pill from Mifepristone displayed on a computer.


Amazon Pharmacy launches same-day prescription delivery in New York and LA
A photograph of an Amazon box with medicines.


Trending on Mashable
NYT Connections today: See hints and answers for March 29
A phone displaying the New York Times game 'Connections.'

Wordle today: Here's the answer and hints for March 29
a phone displaying Wordle

NYT Connections today: See hints and answers for March 28
A phone displaying the New York Times game 'Connections.'

Wordle today: Here's the answer and hints for March 28
a phone displaying Wordle

The biggest stories of the day delivered to your inbox.
This newsletter may contain advertising, deals, or affiliate links. Subscribing to a newsletter indicates your consent to our Terms of Use and Privacy Policy. You may unsubscribe from the newsletters at any time.
Thanks for signing up. See you at your inbox!